Clinical biomarkers directing the management of patients with colon and lung cancer (beyond oncogene-addicted NSCLC)

.blurhash-client-img { display: none !important; }

Open Access

|Sep 2020

Authors

Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Alexandra General Hospital, Athens, Greece

Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Alexandra General Hospital, Athens, Greece

Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Alexandra General Hospital, Athens, Greece

Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Alexandra General Hospital, Athens, Greece

DOI: https://doi.org/10.2478/fco-2019-0014 | Journal eISSN: 1792-362X | Journal ISSN: 1792-345X

Language: English

Page range: 3 - 6

Submitted on: Aug 26, 2019

Accepted on: Nov 5, 2019

Published on: Sep 8, 2020

In partnership with: Paradigm Publishing Services

Publication frequency: 2 issues per year

Keywords:

Related subjects:

© 2020 Ioannis Ntanasis-Stathopoulos, Anastasios Kyriazoglou, Meletios A. Dimopoulos, Maria Gavriatopoulou, published by Helenic Society of Medical Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.